C1416519||ITPR3 gene
C0279671||cervical squamous cell carcinoma
C1556096||Taiwanese
C0043210||women
C0021005||Host immunogenetic
C0343641||human papillomavirus (HPV) infection
C1516170||cervical cancer development
C1416519||Inositol 1,4,5-triphosphate receptor type 3
C1416519||Inositol 1,4,5-triphosphate receptor type 3
C1155000||immune activation
C0006826||cancer
C0699748||pathogenesis
C1416519||Inositol 1,4,5-triphosphate receptor type 3
C0032529||genetic polymorphisms
C1556096||Taiwanese
C0043210||women
C1416519||Inositol 1,4,5-triphosphate receptor type 3
C0752046||rs3748079 A/G
C0752046||rs2229634 C/T polymorphisms
C2603343||hospital-based study
C0043210||women
C0279671||cervical squamous cell carcinoma
C0279671||cervical squamous cell carcinoma
C0043210||women
C0021344||human papillomavirus
C0279671||cervical squamous cell carcinoma
C1416519||Inositol 1,4,5-triphosphate receptor type 3
C0678941||variants
C0279671||cervical squamous cell carcinoma
C4288937||HPV-16 positive
C0279671||cervical squamous cell carcinoma
C0279671||cervical squamous cell carcinoma
C0279671||cervical squamous cell carcinoma
C0999806||HPV-16
C1517888||linkage disequilibrium analysis
C1416519||Inositol 1,4,5-triphosphate receptor type 3
C2717881||association
C0279671||cervical squamous cell carcinoma
C1415576||HLA-DRB1
C0002085||alleles
C1416519||ITPR3 gene
C0017393||potential marker
C0279671||cervical squamous cell carcinoma